Hong Kong stock market anomaly | Huarui Pharmaceuticals-B (02552.HK) rose more than 5% for the first time in the first half of the year, achieving profit for the first time. Huatang Ning's sales performance is strong.
According to the Tencent Finance APP, Hualing Medicine-B (02552.HK) rose more than 5%. As of the time of writing, it has risen by 5.33% to HK$3.36, with a total transaction volume of HK$5.1338 million.
Latest
